| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.004 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |